Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

South Africa’s Aspen agrees initial deal to make J&J vaccine candidate

South Africa’s Aspen agrees initial deal to make J&J vaccine candidate

TANISHA HEIBERG SOUTH African pharmaceutical company Aspen Pharmacare said on Monday it had reached a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate, sending its shares higher. The country's biggest drugmaker said it had agreed to provide capacity required for the manufacture of J&J's vaccine candidate, which is still in clinical trials, at its Port Elizabeth facility. The agreement with J&J will see Aspen perform formulation, filling and secondary packaging of the vaccine for the U.S. firm, the company said. Aspen's shares rose more than 4% on the Johannesburg Stock Exchange on the announcement. The…
Read More